CXCL12 and neoplasm: This study further confirmed that CD26+ NF is converted into a pro-tumor iCAF, which recruits bone marrow cells in a CXCL12-dependent manner and enhances tumor cell invasion through the activity of matrix metalloproteinases (MMPs) (41).